Page last updated: 2024-08-25

honokiol and Malignant Melanoma

honokiol has been researched along with Malignant Melanoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
ElMeshad, A; Ezzeldeen, Y; Sebak, A; Swidan, S1
Arbiser, JL; Chiu, CS; Hsieh, MS; Hsing, HY; Jan, YJ; Lai, DW; Lin, WY; Sheu, ML; Tsai, CH; Tsai, SC; Wu, SM1
Anant, S; Jensen, RA; Kaushik, G; Kwatra, D; Mammen, JM; Subramaniam, D1
Anant, S; Jensen, RA; Kaushik, G; Mammen, JM; Ramamoorthy, P; Standing, D; Subramaniam, D; Umar, S; Venugopal, A1
Kappes, JC; Katiyar, SK; Prasad, R1
Arbiser, JL; Arnold, RS; Bonner, MY; Karlsson, I; Rodolfo, M; Vergani, E1
Dwivedi, C; Guillermo-Lagae, R; Kaushik, RS; Santha, S; Stevens, J; Thomas, M; Zoelle, E1
Mannal, PW; McDonald, D; McFadden, DW; Schneider, J; Tangada, A1
Anant, S; Kaushik, G; Mammen, JM; Protti, P; Ramalingam, S; Rammamoorthy, P; Rangarajan, P; Subramaniam, D1

Other Studies

9 other study(ies) available for honokiol and Malignant Melanoma

ArticleYear
Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma.
    International journal of nanomedicine, 2021, Volume: 16

    Topics: Antineoplastic Agents; Biphenyl Compounds; Humans; Lignans; Melanoma; Tumor Microenvironment

2021
Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
    Cancer letters, 2019, 02-01, Volume: 442

    Topics: Animals; Antineoplastic Agents, Phytogenic; beta Catenin; Biphenyl Compounds; Calpain; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 2; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Lignans; Male; Melanoma; Mice, Inbred BALB C; Mice, Nude; Microphthalmia-Associated Transcription Factor; Peritoneal Neoplasms; Skin Neoplasms; Transcription Factor CHOP; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2019
Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway.
    American journal of surgery, 2014, Volume: 208, Issue:6

    Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Immunoblotting; Lignans; Melanoma; Melanoma, Cutaneous Malignant; Microscopy, Electron, Scanning; Signal Transduction; Skin Neoplasms

2014
Honokiol inhibits melanoma stem cells by targeting notch signaling.
    Molecular carcinogenesis, 2015, Volume: 54, Issue:12

    Topics: ADAM Proteins; ADAM17 Protein; Amyloid Precursor Protein Secretases; Autophagy; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Homeodomain Proteins; Humans; Lignans; Melanoma; Neoplastic Stem Cells; Receptor, Notch2; Receptors, Notch; Signal Transduction; Transcription Factor HES-1

2015
Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.
    Oncotarget, 2016, Feb-16, Volume: 7, Issue:7

    Topics: Animals; Apoptosis; Biphenyl Compounds; Blotting, Western; Cell Membrane; Cell Movement; Cell Proliferation; Cytosol; Enzyme Inhibitors; Female; Fluorescent Antibody Technique; Humans; Lignans; Melanoma; Mice; Mice, Nude; NADPH Oxidase 1; NADPH Oxidases; Oxidative Stress; Protein Binding; Reactive Oxygen Species; Tumor Cells, Cultured; Wound Healing; Xenograft Model Antitumor Assays

2016
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo.
    Oncotarget, 2016, Mar-15, Volume: 7, Issue:11

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Indoles; Lignans; Melanoma; Mice; Signal Transduction; Sulfonamides; Vemurafenib; Xenograft Model Antitumor Assays

2016
Antineoplastic Effects of Honokiol on Melanoma.
    BioMed research international, 2017, Volume: 2017

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Cell Cycle; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Lignans; Male; Melanoma; Mice; Mice, Nude; Neoplasm Proteins; Xenograft Model Antitumor Assays

2017
Honokiol produces anti-neoplastic effects on melanoma cells in vitro.
    Journal of surgical oncology, 2011, Sep-01, Volume: 104, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Blotting, Western; Caspases; Cell Proliferation; Cytochromes c; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Assay; Humans; In Vitro Techniques; Lignans; Melanoma; Tumor Cells, Cultured

2011
Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.
    American journal of surgery, 2012, Volume: 204, Issue:6

    Topics: Amyloid Precursor Protein Secretases; Animals; Antineoplastic Agents, Phytogenic; Autophagy; Biomarkers, Tumor; Biphenyl Compounds; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Immunoblotting; Lignans; Melanoma; Mice; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2012